Iridex reaffirms $51M-$53M 2026 revenue outlook while targeting $600,000 annualized cost reduction (NASDAQ:IRIX)

IRIDEX (IRIX) Q1 2026 earnings call: guidance reaffirmed, cash flow target, G6 growth, retina backlog, margin and cost actions.

Read on WOBR AI →